5ISBT Working Party on Haemovigilance. Proposed standard defini- tions for surveillance of non infectious adverse transfusion reac- tions. 2011-07 [ 2012-06-09 ]. http ://www. ihn-org, com/wp-con- tent/uploads/2011/06/ISBT-definitions-for-non-infectious-transfu- sion-reactions, pdf.
6WHO. WHO draft guidelines for adverse event reporting and learn- ing systems. WHO Document Production Services, Geneva, Switz- erland, 2005, 10.
7张信江.皮肤性病学[M]北京:人民卫生出版社,20097.
8王培华.输血技术学[M]北京:人民卫生出版社,19989.
9Sheila FO,Zou SM. Surveillance of Transfusion*Trans-missible Infections : Comparison of Systems in Five Devel-oped Countries[J]. Transfus Med Rev,2012,26 ( 1) : 38-57.
10Mertes PM. Hypersensitivity reactions to blood compo-nents: document issued by the allergy committee of theFrench medicines and healthcare products regulatory a-gency[J]. J Investig Allergol Clin Immunol,2011,21(3):171-178.
